Catalyst Wire Dossier Catalyst Wire Dossier

NK cell-based immunotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NK cell-based immunotherapy, covering 2018-07-17 to 2018-07-17. Get the full timeline:

Most recent: Clinical Trial Update: NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. [Phase 2]

See pricing